Premium
Fine‐needle aspiration biopsy of HPV‐related squamous cell carcinoma of the head and neck: Current ancillary testing methods for determining HPV status
Author(s) -
Bernadt Cory T.,
Collins Brian T.
Publication year - 2017
Publication title -
diagnostic cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.417
H-Index - 65
eISSN - 1097-0339
pISSN - 8755-1039
DOI - 10.1002/dc.23668
Subject(s) - medicine , head and neck squamous cell carcinoma , fine needle aspiration , biopsy , human papillomavirus , head and neck , cervical lymphadenopathy , carcinoma , radiology , basal cell , cytology , cytopathology , oncology , pathology , head and neck cancer , radiation therapy , surgery , disease
Human papillomavirus (HPV)‐related head and neck squamous cell carcinoma (HNSCC) is a unique form of carcinoma that largely arises from the tonsillar tissue in the oropharynx. These tumors often present with cervical lymphadenopathy resulting in a fine needle aspiration (FNA) biopsy. Use of the cytology specimen to determine the HPV‐status has significant prognostic and treatment implications as HPV‐related tumors have a more favorable prognosis and response to nonsurgical therapies. While several different ancillary testing methods are available that have proven effective for determining HPV status in FNA specimens from HNSCCs, there is currently no consensus regarding HPV testing in this setting. Diagn. Cytopathol. 2017;45:221–229. © 2016 Wiley Periodicals, Inc.